More articles from General Clinical Specialties: Outcomes/Comparative Effectiveness Research

You have access
Direct comparison of neck pinhole (PH) dual tracer (DT) & dual phase (DP) sestamibi accuracies with & without SPECT/CT for parathyroid adenoma (PA) localization
Sherif Heiba, Manli Jiang, Javier Rivera, Hongju Son, Eric Genden, Kaare Weber, William Inabnet, Lale Kostakoglu, Ina Savitch and Josef Machac

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 72;
You have access
Cost-effectiveness of FDG-PET/CT in patients with Gram[+] bacteraemia
Fidel Vos, Chantal Bleeker-Rovers, Bart-Jan Kullberg, Eddy Adang and Wim Oyen

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 67;
You have access
Remnant ablation (RA) success and differentiated thyroid carcinoma (DTC) outcome in Stage III/IV patients: Recombinant human thyrotropin (rhTSH) vs. thyroid hormone withdrawal (THW)
J. Vallejo, L. Mena, M. Gálvez and J. Latre

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 68;
You have access
Ga-68 DOTATOC PET/CT and In-111-DTPA-Octreotide SPECT for staging of enteropancreatic neuroendocrine tumors: Evaluation of costs and consequential costs
Nils Schreiter, Bernd Hamm, Munenobu Nogami, Ulrich-Frank Pape, Ralph Buchert, Winfried Brenner and Martin Maurer

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 70;
You have access
The incidence of clinically important PET-negative CT-positive findings in a large clinical PET/CT practice
Tanche Wang, Jonathan Abele and Johnny Li

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 69;

Main menu